טוען...
Ethical Issues in the Treatment of Late-Stage Alzheimer’s Disease
There is hope that the continuing efforts of researchers will yield a disease-modifying drug for Alzheimer’s disease. Such a drug is likely to be capable of halting, or significantly slowing, the underlying pathological processes driving cognitive decline; however, it is unlikely to be capable of re...
שמור ב:
| הוצא לאור ב: | J Alzheimers Dis |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
IOS Press
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6484269/ https://ncbi.nlm.nih.gov/pubmed/30475773 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-180865 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|